Recruiting studies: Neuroendocrine Ne Tumors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Phase 2 · 1 location(s) · Akiva Mintz · NCT07284589 Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Phase 1 · 2 location(s) · Brigham and Women's Hospital · NCT06062745 Life Following Excision of Neuroendocrine Tumors
Phase N/A · 1 location(s) · Sunnybrook Health Sciences Centre · NCT06981455 Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
Phase N/A · 2 location(s) · Oncology Center of Biochemical Education And Research · NCT06717243 Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms
Phase N/A · 1 location(s) · Uppsala University · NCT07121998 Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06787014 Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Small Bowel
NA · 1 location(s) · European Institute of Oncology · NCT06773624

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.